SCHEMBL3653451

SCHEMBL3653451

CC(Oc1cc2sc(NC(=O)O)nc2cc1Cl)c1c(Cl)ccc(F)c1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 19/20 0.47
KDR P35968 5/20 0.44
FGFR2 P21802 3/20 0.44
AXL P30530 3/20 0.44
FLT3 P36888 3/20 0.44
MST1R Q04912 3/20 0.44
SRC P12931 2/20 0.44
KIT P10721 2/20 0.44
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
KMT2A Q03164 1/20 0.43
ALK Q9UM73 1/20 0.42
AURKA O14965 2/20 0.42
LCK P06239 2/20 0.42
FYN P06241 2/20 0.42
EPHA2 P29317 2/20 0.42
LTK P29376 2/20 0.42
ABL1 P00519 1/20 0.42
YES1 P07947 1/20 0.42
PTK6 Q13882 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3653044 0.94 MET (0.47) METKDRFGFR2AXLFLT3
SCHEMBL3653497 0.93 MET (0.47) METKDRFGFR2AXLFLT3
SCHEMBL3657350 0.89 MET (0.42) METKDRFGFR2AXLFLT3
SCHEMBL3655887 0.87 MET (0.54) METKDRFGFR2AXLFLT3
SCHEMBL3651821 0.86 MET (0.40) METNPC1RAB9AKMT2A
SCHEMBL3656970 0.84 RAB9A (0.43) KITNPC1RAB9AKMT2ALCK
SCHEMBL3650561 0.84 MET (0.42) METKDRFGFR2AXLFLT3
SCHEMBL3105345 0.83 CASP3 (0.51) METKDRSRCNPC1RAB9A
SCHEMBL3652242 0.83 MET (0.41) METKDRFGFR2AXLFLT3
SCHEMBL3104496 0.81 MET (0.43) METKDRFGFR2AXLFLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2205568-A1 6-ARYL/HETEROALKYLOXY BENZOTHIAZOLE AND BENZIMIDAZOLE DERIVATIVES, METHOD FOR PREPARING SAME, APPLICATION THEREOF AS DRUGS, PHARMACEUTICAL COMPOSITIONS AND NOVEL USE IN PARTICULAR AS C-MET INHIBITORS Sanofi-Aventis (FR) 2010-07-14 EP disclosed
WO-2009087305-A1 6-ARYL/HETEROALKYLOXY BENZOTHIAZOLE AND BENZIMIDAZOLE DERIVATIVES, METHOD FOR PREPARING SAME, APPLICATION THEREOF AS DRUGS, PHARMACEUTICAL COMPOSITIONS AND NOVEL USE IN PARTICULAR AS C-MET INHIBITORS SANOFI-AVENTIS (FR) 2009-07-16 WO disclosed